It is a glycoside-sulphate derivative (sucrose) plus aluminum.
At latest update no published data on excretion into breastmilk were found.
Pharmacokinetic data (virtually non-absorbed with a high molecular weight) make it very unlikely the excretion into breastmilk in significant amounts, which in addition it would not be absorbed through the infant's intestine.
Medication with authorized use on infants.
We do not have alternatives for Sucralfate since it is relatively safe.
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
- σουκραλφάτη (Greek)
- سوكرالفات (Arabic)
- Сукральфат (Cyrillic)
- 硫糖铝 (Chinese)
- スクラルファート (Japanese)
- C12H54Al16O75S8 (Molecular formula)
Drug trade names
- Disuo (迪索)™
- Sucrat (Сукрат)™
- Sucrate (素可立)™
- Unival™ (Mexico)
- Venter (Вентер)™
- Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006Abstract Full text (link to original source) Full text (in our servers)
- Richter JE. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther. 2005Abstract Full text (in our servers)
- Broussard CN, Richter JE. Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options? Drug Saf. 1998Abstract
- Hagemann TM. Gastrointestinal medications and breastfeeding. J Hum Lact. 1998Abstract